Roman Nawroth

4.7k total citations
82 papers, 2.1k citations indexed

About

Roman Nawroth is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Roman Nawroth has authored 82 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 30 papers in Pulmonary and Respiratory Medicine and 24 papers in Oncology. Recurrent topics in Roman Nawroth's work include Bladder and Urothelial Cancer Treatments (33 papers), Prostate Cancer Treatment and Research (20 papers) and Urinary and Genital Oncology Studies (12 papers). Roman Nawroth is often cited by papers focused on Bladder and Urothelial Cancer Treatments (33 papers), Prostate Cancer Treatment and Research (20 papers) and Urinary and Genital Oncology Studies (12 papers). Roman Nawroth collaborates with scholars based in Germany, United States and Canada. Roman Nawroth's co-authors include Anuja Sathe, Margitta Retz, Jürgen E. Gschwend, Mark Thalgott, Matthias Heck, Tobias Maurer, Sebastian C. Schmid, Per Sonne Holm, Juergen E. Gschwend and Sara Cervantes and has published in prestigious journals such as Nature Communications, The EMBO Journal and PLoS ONE.

In The Last Decade

Roman Nawroth

77 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roman Nawroth Germany 24 985 601 577 476 321 82 2.1k
Sanaz Memarzadeh United States 23 1.1k 1.1× 439 0.7× 918 1.6× 424 0.9× 260 0.8× 60 2.3k
François Lamoureux France 31 1.6k 1.6× 717 1.2× 830 1.4× 567 1.2× 126 0.4× 73 2.5k
Jeffrey H. Hager United States 17 1.2k 1.2× 631 1.0× 647 1.1× 705 1.5× 188 0.6× 29 2.4k
Young Kyung Bae South Korea 26 1.1k 1.1× 320 0.5× 944 1.6× 691 1.5× 331 1.0× 122 2.5k
Yutaka Hatanaka Japan 27 712 0.7× 653 1.1× 1.2k 2.0× 533 1.1× 335 1.0× 143 2.2k
Todd Hembrough United States 25 942 1.0× 524 0.9× 880 1.5× 653 1.4× 158 0.5× 71 2.3k
Verena Tischler Switzerland 18 1.5k 1.5× 449 0.7× 1.1k 2.0× 578 1.2× 228 0.7× 46 2.7k
Yusuke Nakamura Japan 27 1.5k 1.5× 352 0.6× 773 1.3× 627 1.3× 372 1.2× 84 2.7k
Teijo Kuopio Finland 25 791 0.8× 264 0.4× 886 1.5× 636 1.3× 283 0.9× 119 2.2k
Bungo Furusato United States 26 1.1k 1.2× 1.4k 2.3× 759 1.3× 618 1.3× 185 0.6× 63 2.7k

Countries citing papers authored by Roman Nawroth

Since Specialization
Citations

This map shows the geographic impact of Roman Nawroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman Nawroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman Nawroth more than expected).

Fields of papers citing papers by Roman Nawroth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman Nawroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman Nawroth. The network helps show where Roman Nawroth may publish in the future.

Co-authorship network of co-authors of Roman Nawroth

This figure shows the co-authorship network connecting the top 25 collaborators of Roman Nawroth. A scholar is included among the top collaborators of Roman Nawroth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman Nawroth. Roman Nawroth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Qi, Thomas Engleitner, Rupert Öllinger, et al.. (2024). CDK4/6 inhibition initiates cell cycle arrest by nuclear translocation of RB and induces a multistep molecular response. Cell Death Discovery. 10(1). 453–453. 6 indexed citations
2.
Schober, Sebastian Johannes, Melanie Thiede, Julia Hauer, et al.. (2023). The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma. Clinical Cancer Research. 29(10). 1996–2011. 14 indexed citations
3.
Hensley, Patrick J., Roland Seiler, Harry W. Herr, et al.. (2023). Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1. Urologic Oncology Seminars and Original Investigations. 41(7). 307–312. 1 indexed citations
4.
Ingersoll, Molly A., David C. Müller, Tahlita C.M. Zuiverloon, et al.. (2022). Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III. Urologic Oncology Seminars and Original Investigations. 41(5). 211–218. 3 indexed citations
5.
Zhao, Yuling, Qi Pan, Zhichao Tong, et al.. (2021). Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer. Journal of Personalized Medicine. 11(5). 340–340. 12 indexed citations
6.
Kaissis, Georgios, Geoffrey J. Topping, Jennifer Altomonte, et al.. (2021). Author Correction: Hyperpolarized 13C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC. Scientific Reports. 11(1). 11705–11705. 1 indexed citations
7.
Kaissis, Georgios, Geoffrey J. Topping, Jennifer Altomonte, et al.. (2021). Hyperpolarized 13C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC. Scientific Reports. 11(1). 1191–1191. 18 indexed citations
8.
Heck, Matthias, Florestan Koll, Margitta Retz, et al.. (2020). Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection. Urologic Oncology Seminars and Original Investigations. 38(7). 639.e11–639.e19. 4 indexed citations
9.
Tong, Zhichao, Anuja Sathe, Qi Pan, et al.. (2019). Functional genomics identifies predictive markers and clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 322–322. 27 indexed citations
10.
Heck, Matthias, Margitta Retz, Gregor Weirich, et al.. (2018). Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection. Clinical Cancer Research. 24(10). 2342–2349. 10 indexed citations
11.
Koll, Florestan, Klaus Mantwill, Klaus‐Peter Janssen, et al.. (2018). The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer. Human Gene Therapy. 30(1). 44–56. 18 indexed citations
12.
Hofbauer, Sebastian, Charis Kalogirou, Florian Roghmann, et al.. (2017). [Modern networks : Topics in the working group "Bladder cancer research" of the GeSRU Academics].. PubMed. 56(2). 202–207.
13.
Pan, Qi, Anuja Sathe, Zheming Tong, & Roman Nawroth. (2017). Identification of molecular mechanisms that confer therapy response to CDK4/6 inhibition using a genome-wide CRIPR-dCsa9 gain-of-function screen. Annals of Oncology. 28. vii15–vii15. 1 indexed citations
14.
Holm, Per Sonne, et al.. (2016). YB-1-basierte Virotherapie: Ein neues Therapiekonzept beim Urothelkarzinom der Harnblase. Urologe A. 55(3). 356–363.
15.
Vlahou, Antonia, Peter C. Black, Peter J. Goebell, et al.. (2016). Taking the next step—Advancing bladder cancer management. Urologic Oncology Seminars and Original Investigations. 34(10). 435–436. 1 indexed citations
16.
Nawroth, Roman, Arndt Hartmann, P. Olbert, et al.. (2011). Blasenkarzinom – Update: Was gab es neues auf dem Jahreskongress 2010 der Deutschen Gesellschaft für Urologie in Düsseldorf?. RWTH Publications (RWTH Aachen). 50(2). 221–226. 1 indexed citations
17.
Maurer, Tobias, et al.. (2009). IMMUNOSTIMULATORY CPG-DNA AND PSA-PEPTIDE VACCINATION ELICITS PROFOUND CYTOTOXIC T CELL RESPONSES. The Journal of Urology. 181(4S). 185–185. 2 indexed citations
18.
Autenrieth, Michael, et al.. (2008). Muskelinvasives Urothelkarzinom der Harnblase. Der Urologe. 47(9). 1157–1161. 8 indexed citations
19.
Nawroth, Roman, et al.. (2005). VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts (vol 21, pg 4885, 2002). UCL Discovery (University College London).
20.
Nawroth, Roman, et al.. (1991). [Cholecystectomy and colorectal cancer].. PubMed. 116(5). 311–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanaz Memarzadeh Breakdown of academic impact, for papers by François Lamoureux Breakdown of academic impact, for papers by Jeffrey H. Hager Breakdown of academic impact, for papers by Young Kyung Bae Breakdown of academic impact, for papers by Yutaka Hatanaka Breakdown of academic impact, for papers by Todd Hembrough Breakdown of academic impact, for papers by Verena Tischler Breakdown of academic impact, for papers by Yusuke Nakamura Breakdown of academic impact, for papers by Teijo Kuopio Breakdown of academic impact, for papers by Bungo Furusato
Rankless by CCL
2026